Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Zikani Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Zikani Therapeutics, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H59FN6O10 |
InChIKeyQAXNOKOLLMTSLU-LAUGUCDHSA-N |
CAS Registry1902981-89-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | US | Zikani Therapeutics, Inc.Startup | - |